The Facts: What the Complaint Alleges
On July 2, 2026, Bill Merewhuader filed a class action lawsuit against Tom’s of Maine, Inc. in the United States District Court for the Central District of California. The case number is 2:26-cv-7263. Tom’s is a Maine corporation with its principal place of business in Kennebunk, Maine. The company markets and distributes personal care products nationwide, including in California.
The complaint centers on one product: Tom’s “unscented” deodorant. The front label of the product prominently displays the word “unscented” in large text. The company’s website describes the product as “available in an unscented option for those who prefer a fragrance-free experience.” Reasonable consumers interpret “unscented” to mean free of fragrance. That interpretation is not controversial. That is what the word means.
The product, however, contains Cymbopogon flexuosus oil. This is lemongrass oil. According to the complaint, lemongrass oil has a “strong” “earthy, citrus scent.” The ingredient is listed in the fine-print ingredient panel on the back of the product, buried at the end of a long list of chemical compounds with names like methylheptylglycerin and glyceryl laurate propanediol. The average consumer does not know what Cymbopogon flexuosus oil is. Even if they read the ingredient list, which most do not before purchase, they would not recognize it as fragrance.
Tom’s itself acknowledges that Cymbopogon oil is fragrance. The company maintains an online “Fragrance Disclosure” page. On that page, Tom’s lists Cymbopogon Schoenanthus Oil as a fragrance ingredient. The complaint notes that Cymbopogon Schoenanthus Oil and Cymbopogon flexuosus oil are both oils from the Cymbopogon plant, the scientific genus name for lemongrass, and both have citrusy aromas. Tom’s links to the Fragrance Disclosure on the product’s individual webpage, but the link appears only after a consumer has scrolled past the product image, the “unscented” claim, the purchase options, and the “Add to cart” button. Most consumers never see it. Even fewer click it, scroll through the list, and understand its significance.
The complaint alleges that Tom’s made a label change in approximately January 2026. The new label added a box stating “No Artificial Fragrance or Parabens.” This statement appeared on all scents of Tom’s deodorants, not just the unscented version. The complaint argues this was a brand feature, not a clarification. Consumers saw it as reinforcing the “unscented” claim, not contradicting it.
Plaintiff Bill Merewhuader is a resident of Los Angeles County, California. He purchased the product regularly beginning in early 2025, with his last purchase in approximately June 2026. He bought it from stores such as CVS in Lancaster, California. He was searching for a deodorant free of fragrance. He read and relied on the “unscented” representation. He did not notice the Cymbopogon flexuosus oil in the ingredient list. Even if he had, he would not have understood it to be fragrance. He acted reasonably. Tom’s intentionally placed the “unscented” label on the product to induce consumers like him to purchase it.
The complaint seeks to represent a nationwide class of all persons in the United States who purchased the product for personal or household use during the four years preceding the filing date, and a California subclass. The lawsuit demands injunctive relief, restitution, compensatory damages, punitive damages, and attorneys’ fees.
The Market Context: Why Unscented Products Command a Premium
Consumer demand for unscented skincare and hygiene products has grown drastically in recent years. The complaint cites heightened awareness of health and ingredient safety issues. According to an NIH study referenced in the complaint, the ingredients in fragrance can cause allergies, breast cancer, reproductive disorders, skin allergies, nervous system damage, and migraine headaches. This knowledge has fueled demand for safer, more natural products.
Sensitive skin is on the rise. Studies cited in the complaint suggest that over 50 percent of adults report skin sensitivity. Dermatologists identify fragrance as a common skin irritant that should be avoided by those with sensitive skin. Many fragrances contain allergens that trigger reactions. Fragrance-free options minimize the risk of irritation.
Unscented products are particularly beneficial for consumers with skin sensitivities, allergies, respiratory disorders, or who are otherwise sensitive to perfumes. Some consumers avoid fragrance due to the sensitivities of those around them. The complaint notes that some workplaces prohibit the use of scented products. Other consumers want unscented deodorant so it does not interfere with their perfume or cologne of choice.
“Many consumers are thus willing to pay more for products that are unscented. Unsurprisingly, consumers believe products labeled ‘unscented’ will be in fact unscented.”
The complaint alleges that the product cost more than similar products without misleading labeling and would have cost less absent the false statements. Through the misleading labeling claim, Tom’s was able to gain a greater share of the deodorant market than it would have otherwise and to increase the size of the market. Plaintiff and class members paid more for the product and would have been willing to pay less, or unwilling to purchase it at all, absent the false labeling. The product was worth less than what they paid for it.
The Non-Financial Ledger: What Was Taken Beyond Money
Bill Merewhuader did not lose a large sum of money on a single stick of deodorant. The harm here is not a financial catastrophe. It is something quieter and more corrosive. It is the betrayal of trust in a marketplace that is supposed to be regulated. It is the erosion of the basic assumption that words on a label mean what they say.
Merewhuader has skin sensitivities. He sought out a product specifically because it claimed to be unscented. He made a choice based on his body’s needs. He was deceived. He applied a product to his skin, repeatedly, for over a year, that contained an ingredient he was trying to avoid. The complaint notes that Cymbopogon flexuosus oil’s “fragrance/volatile compounds pose a risk of irritation to skin,” which “can range from noticeable redness, itchiness, and breakout-like rashes to less visible effects like a weakened skin barrier.”
This is not an abstraction. This is a man’s armpits. This is daily exposure to a substance that dermatological guidance recommends people with sensitive skin avoid. The indignity is in the smallness of the deception. Tom’s did not need to lie about this. They could have labeled it “lightly scented” or “naturally scented” or any number of other marketing phrases. They chose “unscented” because they knew it would sell more units.
The complaint identifies a broader class of victims. People with respiratory disorders. People who work in environments with fragrance bans. People who have been told by their doctors to avoid allergens. All of them trusted a label. All of them were wrong to do so. The loss is not just the purchase price of a deodorant stick. The loss is confidence in the system. The loss is the time spent researching products, reading labels, and trying to make informed decisions, only to discover that the company lied in the most straightforward possible way.
There is also the indignity of the defense. Tom’s will argue that the ingredient list was available. That consumers could have read it. That the information was technically disclosed. This argument treats consumers as if they are chemists. As if they should have known that Cymbopogon flexuosus oil is lemongrass oil is fragrance. The law does not require consumers to have a degree in organic chemistry to avoid being defrauded. The law requires labels to be truthful.
Legal Receipts: What Tom’s Said in Its Own Words
“UNSCENTED: Available in an unscented option for those who prefer a fragrance-free experience.”
— Tom’s of Maine product webpage, as quoted in Complaint ¶ 17
“According to an NIH study, the ingredients in fragrance can have adverse effects on health. Components and contaminants in fragrances can cause allergies, breast cancer, reproductive disorders, skin allergies, nervous system damage and migraine headaches.”
— Source cited in Complaint ¶ 10
“[M]any fragrances contain allergens that can trigger reactions. Opting for fragrance-free options helps minimize the risk of irritation and keeps your skin calm and healthy.”
— Dr. Levy, Dermatology of Seattle & Bellevue, as cited in Complaint ¶ 12
“Tom’s acknowledges that Cymbopogon oil is an added fragrance by listing it in an online Fragrance Disclosure.”
— Complaint ¶ 19
“Because the Product is prominently and unambiguously labeled as ‘unscented,’ reasonable consumers usually do not—particularly prior to purchase—read the fine-print ingredients that include Cymbopogon oil at the end of a list of compounds like methylheptylglycerin and glyceryl laurate propanediol, among others.”
— Complaint ¶ 22
“[A] cosmetic shall be deemed to be misbranded . . . [i]f its labeling is false or misleading in any particular.”
— Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 362, as cited in Complaint ¶ 55(d)
“Any cosmetic is misbranded if its labeling is false or misleading in any particular.”
— California Sherman Food, Drug, and Cosmetic Law, Cal. Health & Safety Code § 111730, as cited in Complaint ¶ 55(e)
Societal Impact Mapping: The Ripple Effects
Public Health: The Allergen Exposure Pipeline
When a company lies about fragrance content, it does not just affect one consumer’s purchasing decision. It creates a public health exposure pathway. People with fragrance sensitivities are not a niche demographic. The complaint cites studies showing that over 50 percent of adults report skin sensitivity. That is more than half the country.
Fragrance ingredients are not regulated the way drugs are. Companies are not required to disclose the specific chemicals that make up a “fragrance” on a label. The term is a black box. Consumers who need to avoid certain compounds have no way to know what they are being exposed to unless the product is labeled fragrance-free. When a company labels a fragranced product as unscented, it collapses the entire safety system those consumers rely on.
The complaint notes that dermatologists specifically recommend fragrance-free products for people with sensitive skin. This is not folk wisdom. This is clinical guidance. Tom’s marketed directly to that population. They put the word “unscented” on the label because they knew people with skin sensitivities would buy it. Then they formulated it with an ingredient that dermatological sources identify as posing a “risk of irritation to skin.” This is not negligence. This is targeting.
Economic Inequality: The Premium for a Lie
Unscented products cost more. The complaint alleges that the product cost more than similar products without misleading labeling and would have cost less absent the false statements. This is the economics of deception. Tom’s charged a premium for a feature the product did not have.
The people who pay that premium are disproportionately people who need the product. People with allergies. People with skin conditions. People whose bodies do not tolerate fragrance. They are not paying extra for a luxury. They are paying extra for a necessity. When a company lies about that necessity, it is extracting wealth from people who have no choice but to seek out the product they claim to offer.
The complaint seeks restitution. That means giving the money back. But restitution does not account for the opportunity cost. The time spent researching products. The other purchases not made because the consumer believed they had found the right product. The repeated purchases over months or years. Merewhuader bought the product regularly from early 2025 through June 2026. That is a year and a half of reliance on a lie.
Environmental Degradation: Not Applicable
This case does not involve environmental harm. The misconduct is consumer fraud, not pollution or contamination. No environmental impact section is warranted here.
The Cost of a Lie Metric
What Now? Accountability and Next Steps
The Case: Merewhuader v. Tom’s of Maine, Inc., No. 2:26-cv-7263, filed in the United States District Court for the Central District of California on July 2, 2026.
The Defendant: Tom’s of Maine, Inc., a Maine corporation with its principal place of business in Kennebunk, Maine.
The Legal Claims: Violations of California’s Unfair Competition Law (Cal. Bus. & Prof. Code §§ 17200 et seq.), False Advertising Law (Cal. Bus. & Prof. Code §§ 17500 et seq.), Consumers Legal Remedies Act (Cal. Civ. Code §§ 1750 et seq.), breach of express warranties (Cal. Com. Code § 2313(1)), breach of implied warranty of merchantability (Cal. Com. Code § 2314), and unjust enrichment.
The Counsel: Fitzgerald Monroe Flynn PC, based in San Diego, California. Lead attorneys include Jack Fitzgerald, Melanie R. Monroe, Trevor M. Flynn, Kaden Byron, Allison Ferraro, and Daniel Sachs.
Regulatory Watchlist: The complaint alleges violations of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. §§ 301 et seq.) and the California Sherman Food, Drug, and Cosmetic Law (Cal. Health & Safety Code §§ 110100 et seq.). The relevant regulatory bodies are:
- U.S. Food and Drug Administration (FDA): Responsible for enforcing cosmetic labeling regulations under the Federal Food, Drug, and Cosmetic Act.
- California Department of Public Health: Enforces the California Sherman Food, Drug, and Cosmetic Law.
- Federal Trade Commission (FTC): Has authority over false advertising in interstate commerce.
What You Can Do:
If you purchased Tom’s of Maine “unscented” deodorant during the class period (the four years preceding July 2, 2026, through the date of class notification), you may be a class member. Monitor the case docket for notices regarding class certification and claim procedures. Contact the law firm listed above if you wish to inquire about your eligibility.
On a systemic level, this case is a reminder that consumer protection law exists because companies will lie if it is profitable to do so. The regulatory agencies listed above only act when they receive complaints. If you encounter a mislabeled product, file a complaint with the FDA, FTC, or your state’s consumer protection office. Those complaints create the paper trail that leads to enforcement actions.
Support legislative efforts to strengthen cosmetic labeling requirements. The FDA does not pre-approve cosmetics the way it does drugs. Cosmetic companies are largely on the honor system. That system does not work when honor is not profitable. Advocate for mandatory third-party testing and clearer disclosure requirements for fragrance ingredients.
Finally, share this story. The complaint alleges that Tom’s sold this product nationwide. There are class members in every state who do not yet know they were defrauded. Sunlight is the best disinfectant. Make sure they see the light.
The source document for this investigation is attached below.
